Back to Mobile View
Subscribe to the CrunchBase Daily for the latest on Fundings, Acquisitions, and Startup Events

Exit

Acquired byIllumina
Date1/2013

General Information

Offices

Redwood City, USA
800 Saginaw Drive
Redwood City, CA, 94063
USA

People

CEO
CEO
Vice President, Finance and Administration
President

Funding

TOTAL $58.3M
FUNDING TOTAL $58.3M
Partial Close, 10/2009
$9M
Series C, 8/2011
Mohr Davidow Ventures
Sutter Hill Ventures
Alloy Ventures
$48.5M
Series C, 5/2012
$750k

Tags

Verinata Health

Verinata is driven by a sole, extraordinary purpose – maternal and fetal health. Our initial focus is to develop and offer non-invasive tests for early identification of fetal chromosomal abnormalities using our proprietary technologies. We aim to reduce the anxiety associated with today’s multi-step process, the unacceptable false-positive rates, the non-specific and sometimes confusing results of current prenatal screening methods, as well as the risk of current invasive procedures. In support of national guidelines recommending first trimester aneuploidy risk assessment, we believe women who desire such an assessment should be offered a single blood draw test with a definitive result. Verinata is conducting a prospective, blinded pivotal study to clinically validate the sensitivity and specificity of its first prenatal test on a large scale with results of the study expected in 2011.

Recent Milestones

Videos

Screenshots

Sources

  1. Illumina Acquires Verinata Health, Prenatal Testmaker, For $350M (xconomy.com) [edit]
  2. SEC (sec.gov) [edit]
  3. Verinata Health Closes $46.5M Series C Financing (finsmes.com) [edit]
  4. SEC (sec.gov) [edit]
Edit This Page
Last Edited 3/14/14

Revision History RSS Picture

Sharing

Share this page on Twitter or Facebook:
Or copy this code to embed a widget: customize »

External Links

CrunchBase API

Sponsors



Become a Sponsor
Terms of Service | Privacy Policy | Licensing Policy